 The abstract background of this paper discusses the ethics of conducting clinical trials on selective digestive decontamination, STD. It then goes on to describe how the results of these trials have been inconsistent, leading to the conclusion that there may be a spillover effect from STD that could cause harm to patients. This effect has not yet been proven, but if it exists, it could lead to serious consequences. This article was authored by James C. Hurley.